P2RX7: A receptor with a split personality in inflammation and cancer
Open Access
- 3 February 2015
- journal article
- opinion
- Published by Taylor & Francis in Molecular & Cellular Oncology
- Vol. 3 (2) , e1010937
Abstract
P2X7 (also known as P2RX7) is a plasma membrane receptor for extracellular ATP that is expressed at a high level by immune and tumor cells. Previous data showed that increased P2rx7 expression by tumor cells accelerates tumor progression. We have now looked at the other side of the relationship by investigating the effect of a lack of host P2rx7 expression on tumor growth. Our novel observations highlight a surprising role of host P2rx7 in restraining tumor progression.Keywords
This publication has 10 references indexed in Scilit:
- Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated CancerCancer Research, 2015
- Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7Cancer Research, 2015
- ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironmentCell Death & Disease, 2014
- Purinergic signalling: from discovery to current developmentsExperimental Physiology, 2014
- Purines, Purinergic Receptors, and CancerCancer Research, 2012
- Expression of P2X7 Receptor IncreasesIn VivoTumor GrowthCancer Research, 2012
- P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasivenessOncogene, 2011
- Graft-versus-host disease is enhanced by extracellular ATP activating P2X7RNature Medicine, 2010
- Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATPJournal of the Autonomic Nervous System, 2000
- Responses of mouse lymphocytes to extracellular adenosine 5'-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP.The Journal of Immunology, 1989